TY - JOUR
T1 - Prognostic model of survival for typical bronchial carcinoid tumours
T2 - Analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group
AU - ESTS NETs-WG Steering Committee
AU - Filosso, Pier Luigi
AU - Guerrera, Francesco
AU - Evangelista, Andrea
AU - Welter, Stefan
AU - Thomas, Pascal
AU - Casado, Paula Moreno
AU - Rendina, Erino Angelo
AU - Venuta, Federico
AU - Ampollini, Luca
AU - Brunelli, Alessandro
AU - Stella, Franco
AU - Nosotti, Mario
AU - Raveglia, Federico
AU - Larocca, Valentina
AU - Rena, Ottavio
AU - Margaritora, Stefano
AU - Ardissone, Francesco
AU - Travis, William D.
AU - Sarkaria, Inderpal
AU - Sagan, Dariusz
AU - Yuste, Mariano Garcia
AU - Lim, Eric
AU - Papagiannopoulos, Konstantinos
AU - Asamura, Hisao
N1 - Publisher Copyright:
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.
PY - 2015/9
Y1 - 2015/9
N2 - OBJECTIVES: Typical carcinoids (TCs) are uncommon, slow-growing neoplasms, usually with high 5-year survival rates. As these are rare tumours, their management is still based on small clinical observations and no international guidelines exist. Based on the European Society of Thoracic Surgeon Neuroendocrine TumoursWorking Group (NET-WG) Database, we evaluated factors that may influence TCs mortality. METHODS: Using the NET-WG database, an analysis on TC survival was performed. Overall survival (OS) was calculated starting from the date of intervention. Predictors of OS were investigated using the Cox model with shared frailty (accounting for the within-centre correlation). Candidate predictors were: gender, age, smoking habit, tumour location, previous malignancy, Eastern Cooperative Oncology Group (ECOG) performance status (PS), pT, pN, TNM stage and tumour vascular invasion. The final model included predictors with P = 0.15 after a backward selection. Missing data in the evaluated predictors were multiple-imputed and combined estimates were obtained from five imputed data sets. RESULTS: For 58 of 1167 TC patients vital status was unavailable and analyses were therefore performed on 1109 patients from 17 institutions worldwide. During a median follow-up of 50 months, 87 patients died, with a 5-year OS rate of 93.7% (95% confidence interval: 91.7-95.3). Backward selection resulted in a prediction model for mortality containing age, gender, previous malignancies, peripheral tumour, TNM stage and ECOG PS. The final model showed a good discrimination ability with a C-statistic equal to 0.836 (bootstrap optimism-corrected 0.806). CONCLUSIONS: We presented and validated a promising prognostic model for TC survival, showing good calibration and discrimination ability. Further analyses are needed and could be focused on an external validation of this model.
AB - OBJECTIVES: Typical carcinoids (TCs) are uncommon, slow-growing neoplasms, usually with high 5-year survival rates. As these are rare tumours, their management is still based on small clinical observations and no international guidelines exist. Based on the European Society of Thoracic Surgeon Neuroendocrine TumoursWorking Group (NET-WG) Database, we evaluated factors that may influence TCs mortality. METHODS: Using the NET-WG database, an analysis on TC survival was performed. Overall survival (OS) was calculated starting from the date of intervention. Predictors of OS were investigated using the Cox model with shared frailty (accounting for the within-centre correlation). Candidate predictors were: gender, age, smoking habit, tumour location, previous malignancy, Eastern Cooperative Oncology Group (ECOG) performance status (PS), pT, pN, TNM stage and tumour vascular invasion. The final model included predictors with P = 0.15 after a backward selection. Missing data in the evaluated predictors were multiple-imputed and combined estimates were obtained from five imputed data sets. RESULTS: For 58 of 1167 TC patients vital status was unavailable and analyses were therefore performed on 1109 patients from 17 institutions worldwide. During a median follow-up of 50 months, 87 patients died, with a 5-year OS rate of 93.7% (95% confidence interval: 91.7-95.3). Backward selection resulted in a prediction model for mortality containing age, gender, previous malignancies, peripheral tumour, TNM stage and ECOG PS. The final model showed a good discrimination ability with a C-statistic equal to 0.836 (bootstrap optimism-corrected 0.806). CONCLUSIONS: We presented and validated a promising prognostic model for TC survival, showing good calibration and discrimination ability. Further analyses are needed and could be focused on an external validation of this model.
KW - Lung
KW - Metastases
KW - Neuroendocrine tumours
KW - Prognostic score
KW - Recurrence
KW - Surgery
KW - Survival
KW - Typical carcinoid
UR - http://www.scopus.com/inward/record.url?scp=84924585552&partnerID=8YFLogxK
U2 - 10.1093/ejcts/ezu495
DO - 10.1093/ejcts/ezu495
M3 - Article
SN - 1010-7940
VL - 48
SP - 441
EP - 447
JO - European Journal of Cardio-thoracic Surgery
JF - European Journal of Cardio-thoracic Surgery
IS - 3
ER -